These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1473578)

  • 1. L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, inhibits dopamine release and metabolism in the rat striatum in vivo.
    Mizoguchi K; Tanaka M; Yokoo H; Yoshida M; Tsuda A
    Experientia; 1992 Dec; 48(11-12):1133-4. PubMed ID: 1473578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
    Maruyama W; Nakahara D; Naoi M
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: a microdialysis study.
    Sarre S; Smolders I; Thorré K; Ebinger G; Michotte Y
    J Neural Transm (Vienna); 1997; 104(11-12):1215-28. PubMed ID: 9503267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
    Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propentofylline (HWA285) inhibits the release of dopamine during transient ischemia and modulates its metabolism in rat striatum.
    Shimizu K; Ogino M; Yamaguchi N; Mitani S; Saito R; Kawase T; Toya S
    Neurosci Lett; 1993 Aug; 158(1):9-12. PubMed ID: 8233079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study.
    Nowak P; Brus R; Oświecimska J; Sokoła A; Kostrzewa RM
    J Physiol Pharmacol; 2002 Jun; 53(2):251-63. PubMed ID: 12120900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P
    Gen Pharmacol; 1993 Jan; 24(1):75-81. PubMed ID: 8482506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
    Miyamae T; Yue JL; Goshima Y; Misu Y
    Eur J Pharmacol; 1996 Apr; 300(1-2):105-8. PubMed ID: 8741173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
    Serra PA; Esposito G; Enrico P; Mura MA; Migheli R; Delogu MR; Miele M; Desole MS; Grella G; Miele E
    Br J Pharmacol; 2000 Jun; 130(4):937-45. PubMed ID: 10864903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
    Harada H; Noto T; Tsuji M; Taga C; Hashimoto H; Nakajima T
    Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
    Hirose A; Sasa M; Ohno Y; Takaori S
    Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-threo-DOPS, a noradrenaline precursor, on the long-term potentiation in the rat hippocampal mossy fiber-CA3 region.
    Sakai N; Sasa M; Ishihara K; Komure O; Tanaka C; Takaori S
    Brain Res; 1991 Dec; 567(2):267-73. PubMed ID: 1817730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-dopa-like regulatory actions of L-threo-3,4-dihydroxyphenylserine on the release of endogenous noradrenaline via presynaptic receptors in rat hypothalamic slices.
    Yue JL; Goshima Y; Nakamura S; Misu Y
    J Pharm Pharmacol; 1992 Dec; 44(12):990-5. PubMed ID: 1361565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.